{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:00:45Z","timestamp":1790704845120,"version":"4.1.0"},"reference-count":217,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.antiviral.2009.08.002","type":"journal-article","created":{"date-parts":[[2009,8,13]],"date-time":"2009-08-13T08:25:38Z","timestamp":1250151938000},"page":"101-118","source":"Crossref","is-referenced-by-count":72,"title":["Reverse genetics technology for Rift Valley fever virus: Current and future applications for the development of therapeutics and vaccines"],"prefix":"10.1016","volume":"84","author":[{"given":"Michele","family":"Bouloy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Flick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2009.08.002_bib1","doi-asserted-by":"crossref","first-page":"741","DOI":"10.20506\/rst.18.3.1195","article-title":"An epizootic of Rift Valley fever in Egypt in 1997","volume":"18","author":"Abd el-Rahim","year":"1999","journal-title":"Rev. Sci. Tech."},{"key":"10.1016\/j.antiviral.2009.08.002_bib2","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.virol.2004.12.030","article-title":"Kinetics of expansion of SIV Gag-specific CD8+ T lymphocytes following challenge of vaccinated macaques","volume":"333","author":"Abdel-Motal","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2009.08.002_bib3","doi-asserted-by":"crossref","first-page":"9131","DOI":"10.1128\/JVI.00647-07","article-title":"Immunogenicity of influenza virus vaccine is increased by anti-gal-mediated targeting to antigen-presenting cells","volume":"81","author":"Abdel-Motal","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib4","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1016\/j.vaccine.2009.03.019","article-title":"Mechanism for increased immunogenicity of vaccines that form in vivo immune complexes with the natural anti-Gal antibody","volume":"27","author":"Abdel-Motal","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2009.08.002_bib5","first-page":"155","article-title":"Prevalence of anti-Rift-Valley-fever IgM antibody in abattoir workers in the Nile delta during the 1993 outbreak in Egypt","volume":"74","author":"Abu-Elyazeed","year":"1996","journal-title":"Bull. World Health Org."},{"key":"10.1016\/j.antiviral.2009.08.002_bib6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1086\/345671","article-title":"Epidemic Rift Valley fever in Saudi Arabia: a clinical study of severe illness in humans","volume":"36","author":"Al-Hazmi","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2009.08.002_bib7","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.1128\/JVI.02778-06","article-title":"A shared transcription termination signal on negative and ambisense RNA genome segments of Rift Valley fever, sandfly fever Sicilian, and Toscana viruses","volume":"81","author":"Albarino","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib8","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3201\/eid1003.020817","article-title":"Rift Valley fever encephalitis","volume":"10","author":"Alrajhi","year":"2004","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2009.08.002_bib9","doi-asserted-by":"crossref","first-page":"475","DOI":"10.4269\/ajtmh.1991.44.475","article-title":"Infection of inbred rat strains with Rift Valley fever virus: development of a congenic resistant strain and observations on age-dependence of resistance","volume":"44","author":"Anderson","year":"1991","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2009.08.002_bib10","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0882-4010(88)90096-4","article-title":"Viral determinants of virulence for Rift Valley fever (RVF) in rats","volume":"5","author":"Anderson","year":"1988","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.antiviral.2009.08.002_bib11","doi-asserted-by":"crossref","first-page":"9585","DOI":"10.1128\/JVI.72.12.9585-9596.1998","article-title":"Targeting of a short peptide derived from the cytoplasmic tail of the G1 membrane glycoprotein of Uukuniemi virus (Bunyaviridae) to the Golgi complex","volume":"72","author":"Andersson","year":"1998","journal-title":"J. Virol."},{"issue":"Pt 5","key":"10.1016\/j.antiviral.2009.08.002_bib12","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/icb.1989.48","article-title":"Humoral and cell-mediated immune responses to recombinant vaccinia viruses in mice","volume":"67","author":"Andrew","year":"1989","journal-title":"Immunol. Cell Biol."},{"issue":"August\u2013October","key":"10.1016\/j.antiviral.2009.08.002_bib13","first-page":"392","article-title":"Outbreak of Rift Valley fever, Yemen","volume":"75","author":"Anonymous","year":"2000","journal-title":"Wkly. Epidemiol. Rec."},{"key":"10.1016\/j.antiviral.2009.08.002_bib14","unstructured":"Anonymous, 2009. Chemical and Biological Weapons: Possession and Programs Past and Present. CNS, James Martin Center for Nonproliferation Studies. Available online at: http:\/\/cns.miis.edu\/cbw\/possess.htm."},{"key":"10.1016\/j.antiviral.2009.08.002_bib15","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/0140-6736(93)92128-G","article-title":"Recurrence of Rift Valley fever in Egypt","volume":"342","author":"Arthur","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2009.08.002_bib16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0924-8579(02)00295-9","article-title":"Rift Valley fever: an uninvited zoonosis in the Arabian peninsula","volume":"21","author":"Balkhy","year":"2003","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.antiviral.2009.08.002_bib17","first-page":"155","article-title":"Rift Valley fever vaccine\u2014antibody and immune response in cattle to a live and an inactivated vaccine","volume":"50","author":"Barnard","year":"1979","journal-title":"J. S. Afr. Vet. Assoc."},{"key":"10.1016\/j.antiviral.2009.08.002_bib18","first-page":"45","article-title":"An inactivated rift valley fever vaccine","volume":"48","author":"Barnard","year":"1977","journal-title":"J. S. Afr. Vet. Assoc."},{"key":"10.1016\/j.antiviral.2009.08.002_bib19","doi-asserted-by":"crossref","first-page":"12602","DOI":"10.1128\/JVI.79.19.12602-12607.2005","article-title":"The Bunyamwera virus mRNA transcription signal resides within both the 3\u2032 and the 5\u2032 terminal regions and allows ambisense transcription from a model RNA segment","volume":"79","author":"Barr","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib20","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1128\/JVI.79.6.3586-3594.2005","article-title":"Role of the conserved nucleotide mismatch within 3\u2032- and 5\u2032-terminal regions of Bunyamwera virus in signaling transcription","volume":"79","author":"Barr","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.antiviral.2008.01.003","article-title":"Current and future antiviral therapy of severe seasonal and avian influenza","volume":"78","author":"Beigel","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2009.08.002_bib22","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1128\/JVI.61.12.3960-3967.1987","article-title":"Translational requirement for La Crosse virus S-mRNA synthesis: a possible mechanism","volume":"61","author":"Bellocq","year":"1987","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib23","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1371\/journal.ppat.0020051","article-title":"Envelope exchange for the generation of live-attenuated arenavirus vaccines","volume":"2","author":"Bergthaler","year":"2006","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2009.08.002_bib24","unstructured":"Bettinger, G.E., Peters, C.J., Pittman, P., Morrill, J.C., Ranadive, M., Kormann, R.N., Lokukamage, N., 2009. Rift Valley fever MP-12 vaccine: a university, government, & industry collaborative development. Rift Valley Fever Workshop."},{"key":"10.1016\/j.antiviral.2009.08.002_bib25","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.virol.2008.05.033","article-title":"RNA polymerase I-mediated expression of viral RNA for the rescue of infectious virulent and avirulent Rift Valley fever viruses","volume":"378","author":"Billecocq","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2009.08.002_bib26","doi-asserted-by":"crossref","first-page":"9798","DOI":"10.1128\/JVI.78.18.9798-9806.2004","article-title":"NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription","volume":"78","author":"Billecocq","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib27","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1128\/JVI.02501-07","article-title":"Rift valley fever virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge, and allows for differential identification of infected and vaccinated animals","volume":"82","author":"Bird","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.virol.2007.01.046","article-title":"Rift Valley fever virus lacking NSm proteins retains high virulence in vivo and may provide a model of human delayed onset neurologic disease","volume":"362","author":"Bird","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2009.08.002_bib29","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1128\/JVI.02095-06","article-title":"Complete genome analysis of 33 ecologically and biologically diverse Rift Valley fever virus strains reveals widespread virus movement and low genetic diversity due to recent common ancestry","volume":"81","author":"Bird","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib30","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1128\/JVI.01933-06","article-title":"La Crosse bunyavirus nonstructural protein NSs serves to suppress the type I interferon system of mammalian hosts","volume":"81","author":"Blakqori","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib31","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1099\/vir.0.18876-0","article-title":"Functional L polymerase of La Crosse virus allows in vivo reconstitution of recombinant nucleocapsids","volume":"84","author":"Blakqori","year":"2003","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib32","doi-asserted-by":"crossref","first-page":"10420","DOI":"10.1128\/JVI.79.16.10420-10428.2005","article-title":"Efficient cDNA-based rescue of La Crosse bunyaviruses expressing or lacking the nonstructural protein NSs","volume":"79","author":"Blakqori","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib33","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/jmv.20624","article-title":"Adverse response of non-indigenous cattle of European breeds to live attenuated Smithburn Rift Valley fever vaccine","volume":"78","author":"Botros","year":"2006","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib34","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1128\/JVI.75.3.1371-1377.2001","article-title":"Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs","volume":"75","author":"Bouloy","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2007.12.007","article-title":"Highly pathogenic RNA viral infections: challenges for antiviral research","volume":"78","author":"Bray","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2009.08.002_bib36","doi-asserted-by":"crossref","first-page":"15400","DOI":"10.1073\/pnas.93.26.15400","article-title":"Rescue of a segmented negative-strand RNA virus entirely from cloned complementary DNAs","volume":"93","author":"Bridgen","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2009.08.002_bib37","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1073\/pnas.98.2.664","article-title":"Bunyamwera bunyavirus nonstructural protein NSs is a nonessential gene product that contributes to viral pathogenesis","volume":"98","author":"Bridgen","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2009.08.002_bib38","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1128\/JVI.74.3.1187-1199.2000","article-title":"Chimeric bovine respiratory syncytial virus with glycoprotein gene substitutions from human respiratory syncytial virus (HRSV): effects on host range and evaluation as a live-attenuated HRSV vaccine","volume":"74","author":"Buchholz","year":"2000","journal-title":"J. Virol."},{"issue":"Pt 10","key":"10.1016\/j.antiviral.2009.08.002_bib39","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1099\/0022-1317-66-10-2271","article-title":"Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development","volume":"66","author":"Caplen","year":"1985","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib40","doi-asserted-by":"crossref","first-page":"5902","DOI":"10.1128\/JVI.65.11.5902-5909.1991","article-title":"Oligomerization, transport, and Golgi retention of Punta Toro virus glycoproteins","volume":"65","author":"Chen","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib41","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0042-6822(91)90148-5","article-title":"Golgi complex localization of the Punta Toro virus G2 protein requires its association with the G1 protein","volume":"183","author":"Chen","year":"1991","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2009.08.002_bib42","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/sj.gt.3302267","article-title":"Adenovirus-based vascular endothelial growth factor gene delivery to human pancreatic islets","volume":"11","author":"Cheng","year":"2004","journal-title":"Gene Ther."},{"key":"10.1016\/j.antiviral.2009.08.002_bib43","first-page":"119","article-title":"Hydrops amnii in sheep associated with hydranencephaly and arthrogryposis with wesselsbron disease and rift valley fever viruses as aetiological agents","volume":"44","author":"Coetzer","year":"1977","journal-title":"Onderstepoort J. Vet. Res."},{"key":"10.1016\/j.antiviral.2009.08.002_bib44","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/0042-6822(91)90435-E","article-title":"An L (polymerase)-deficient rabies virus defective interfering particle RNA is replicated and transcribed by heterologous helper virus L proteins","volume":"184","author":"Conzelmann","year":"1991","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2009.08.002_bib45","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1099\/vir.0.82452-0","article-title":"A reverse-genetics system for Influenza A virus using T7 RNA polymerase","volume":"88","author":"de Wit","year":"2007","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib46","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1128\/AAC.00069-07","article-title":"In vitro resistance selection and in vivo efficacy of morpholino oligomers against West Nile virus","volume":"51","author":"Deas","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2009.08.002_bib47","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0923-2516(89)80081-0","article-title":"General aspects of the 1987 Rift Valley fever epidemic in Mauritania","volume":"140","author":"Digoutte","year":"1989","journal-title":"Res. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib48","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1006\/viro.1995.1386","article-title":"Transcription of a recombinant bunyavirus RNA template by transiently expressed bunyavirus proteins","volume":"211","author":"Dunn","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2009.08.002_bib49","first-page":"65","article-title":"Rift valley fever","volume":"10","author":"Easterday","year":"1965","journal-title":"Adv. Vet. Sci."},{"key":"10.1016\/j.antiviral.2009.08.002_bib50","series-title":"The Bunyaviridae","author":"Elliott","year":"1996"},{"key":"10.1016\/j.antiviral.2009.08.002_bib51","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.1128\/JVI.75.13.6107-6114.2001","article-title":"Rearrangement of the genes of vesicular stomatitis virus eliminates clinical disease in the natural host: new strategy for vaccine development","volume":"75","author":"Flanagan","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib52","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1073\/pnas.0600652103","article-title":"Recovery of an arenavirus entirely from RNA polymerase I\/II-driven cDNA","volume":"103","author":"Flatz","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2009.08.002_bib53","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0042-6822(02)00070-3","article-title":"Rescue of Hantaan virus minigenomes","volume":"306","author":"Flick","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2009.08.002_bib54","doi-asserted-by":"crossref","first-page":"11726","DOI":"10.1128\/JVI.78.21.11726-11738.2004","article-title":"Functional analysis of the noncoding regions of the Uukuniemi virus (Bunyaviridae) RNA segments","volume":"78","author":"Flick","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib55","unstructured":"Flick, R., 2009. Unpublished data."},{"key":"10.1016\/j.antiviral.2009.08.002_bib56","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2174\/156652405774962263","article-title":"Rift Valley fever virus","volume":"5","author":"Flick","year":"2005","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.antiviral.2009.08.002_bib57","doi-asserted-by":"crossref","first-page":"5997","DOI":"10.1128\/JVI.77.10.5997-6006.2003","article-title":"Reverse genetics for crimean-congo hemorrhagic fever virus","volume":"77","author":"Flick","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib58","first-page":"407","article-title":"The alphaGal HyperAcute\u00ae Technology: enhancing immunogenicity of antiviral vaccines by exploiting the natural alphagal-mediated zoonotic blockade","volume":"56","author":"Flick","year":"2009","journal-title":"Zoonoses Public Health"},{"key":"10.1016\/j.antiviral.2009.08.002_bib59","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1128\/JVI.75.4.1643-1655.2001","article-title":"Reverse genetics system for Uukuniemi virus (Bunyaviridae): RNA polymerase I-catalyzed expression of chimeric viral RNAs","volume":"75","author":"Flick","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib60","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2174\/156652405774962335","article-title":"Crimean-Congo hemorrhagic fever virus","volume":"5","author":"Flick","year":"2005","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.antiviral.2009.08.002_bib61","doi-asserted-by":"crossref","first-page":"9679","DOI":"10.1128\/JVI.73.11.9679-9682.1999","article-title":"Rescue of influenza A virus from recombinant DNA","volume":"73","author":"Fodor","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib62","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3201\/eid0402.980218","article-title":"New vectors of Rift Valley fever in West Africa","volume":"4","author":"Fontenille","year":"1998","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2009.08.002_bib63","first-page":"89","article-title":"Response of laboratory staff to vaccination with an inactivated Rift Valley fever vaccine\u2014TSI-GSD 200","volume":"29","author":"Frank-Peterside","year":"2000","journal-title":"Afr. J. Med. Med. Sci."},{"key":"10.1016\/j.antiviral.2009.08.002_bib64","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.virol.2007.08.008","article-title":"Establishment and characterization of plasmid-driven minigenome rescue systems for Nipah virus: RNA polymerase I- and T7-catalyzed generation of functional paramyxoviral RNA","volume":"370","author":"Freiberg","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2009.08.002_bib65","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.ymthe.2003.08.021","article-title":"Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain","volume":"8","author":"Fu","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.antiviral.2009.08.002_bib66","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.antiviral.2009.02.198","article-title":"T-705 (favipiravir) and related compounds: novel broad-spectrum inhibitors of RNA viral infections","volume":"82","author":"Furuta","year":"2009","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2009.08.002_bib67","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1099\/vir.0.83449-0","article-title":"Morpholino oligomers targeting the PB1 and NP genes enhance the survival of mice infected with highly pathogenic influenza A H7N7 virus","volume":"89","author":"Gabriel","year":"2008","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib68","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF00201098","article-title":"Evolution and pathophysiology of the human natural anti-alpha-galactosyl IgG (anti-Gal) antibody","volume":"15","author":"Galili","year":"1993","journal-title":"Springer Semin. Immunopathol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib69","first-page":"1","article-title":"Evolution of alpha 1,3galactosyltransferase and of the alpha-Gal epitope","volume":"32","author":"Galili","year":"1999","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.antiviral.2009.08.002_bib70","first-page":"158","article-title":"Excessive binding of the natural anti-alpha-galactosyl IgG to sickle red cells: enhancement of red cell destruction by a physiological process","volume":"98","author":"Galili","year":"1985","journal-title":"Trans. Assoc. Am. Physicians"},{"key":"10.1016\/j.antiviral.2009.08.002_bib71","first-page":"263","article-title":"A naturally occurring anti-alpha-galactosyl IgG recognizing senescent human red cells","volume":"195","author":"Galili","year":"1985","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1016\/j.antiviral.2009.08.002_bib72","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1084\/jem.162.2.573","article-title":"Human natural anti-alpha-galactosyl IgG. II. The specific recognition of alpha (1\u20133)-linked galactose residues","volume":"162","author":"Galili","year":"1985","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2009.08.002_bib73","doi-asserted-by":"crossref","first-page":"4676","DOI":"10.4049\/jimmunol.178.7.4676","article-title":"Intratumoral injection of alpha-gal glycolipids induces xenograft-like destruction and conversion of lesions into endogenous vaccines","volume":"178","author":"Galili","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib74","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1128\/JCM.39.12.4456-4461.2001","article-title":"Quantitative real-time PCR detection of Rift Valley fever virus and its application to evaluation of antiviral compounds","volume":"39","author":"Garcia","year":"2001","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib75","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.virol.2006.03.018","article-title":"Rift Valley fever virus noncoding regions of L, M and S segments regulate RNA synthesis","volume":"351","author":"Gauliard","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2009.08.002_bib76","doi-asserted-by":"crossref","first-page":"613","DOI":"10.20506\/rst.23.2.1500","article-title":"Rift Valley fever","volume":"23","author":"Gerdes","year":"2004","journal-title":"Rev. Sci. Tech."},{"key":"10.1016\/j.antiviral.2009.08.002_bib77","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.virol.2006.09.035","article-title":"The NSm proteins of Rift Valley fever virus are dispensable for maturation, replication and infection","volume":"359","author":"Gerrard","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2009.08.002_bib78","doi-asserted-by":"crossref","first-page":"12200","DOI":"10.1128\/JVI.76.23.12200-12210.2002","article-title":"Characterization of the Golgi retention motif of Rift Valley fever virus G(N) glycoprotein","volume":"76","author":"Gerrard","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib79","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.virol.2006.08.002","article-title":"Synthesis, proteolytic processing and complex formation of N-terminally nested precursor proteins of the Rift Valley fever virus glycoproteins","volume":"357","author":"Gerrard","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2009.08.002_bib80","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.antiviral.2007.10.002","article-title":"Animal models of highly pathogenic RNA viral infections: hemorrhagic fever viruses","volume":"78","author":"Gowen","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2009.08.002_bib81","doi-asserted-by":"crossref","first-page":"e3725","DOI":"10.1371\/journal.pone.0003725","article-title":"Treatment of late stage disease in a model of arenaviral hemorrhagic fever: T-705 efficacy and reduced toxicity suggests an alternative to ribavirin","volume":"3","author":"Gowen","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2009.08.002_bib82","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1128\/AAC.00356-07","article-title":"In vitro and in vivo activities of T-705 against arenavirus and bunyavirus infections","volume":"51","author":"Gowen","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2009.08.002_bib83","series-title":"World At Risk: The Report of the Commission on the Prevention of WMD Proliferation and Terrorism","author":"Graham","year":"2008"},{"key":"10.1016\/j.antiviral.2009.08.002_bib84","first-page":"40","article-title":"Virus-like particles; passport to immune recognition","author":"Grgacic","year":"2006","journal-title":"Methods"},{"key":"10.1016\/j.antiviral.2009.08.002_bib85","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1128\/JVI.79.7.4425-4433.2005","article-title":"RNA polymerase I-driven minigenome system for Ebola viruses","volume":"79","author":"Groseth","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib86","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.vaccine.2006.10.048","article-title":"Long-term humoral and cell-mediated immunity after acellular pertussis vaccination compares favourably with whole-cell vaccines 6 years after booster vaccination in the second year of life","volume":"25","author":"Guiso","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2009.08.002_bib87","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s11248-007-9107-x","article-title":"The commonly used beta-actin-GFP transgenic mouse strain develops a distinct type of glomerulosclerosis","volume":"16","author":"Guo","year":"2007","journal-title":"Transgenic Res."},{"key":"10.1016\/j.antiviral.2009.08.002_bib88","doi-asserted-by":"crossref","first-page":"e2032","DOI":"10.1371\/journal.pone.0002032","article-title":"Processing of genome 5\u2032 termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction","volume":"3","author":"Habjan","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2009.08.002_bib89","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1099\/vir.0.2008\/002097-0","article-title":"T7 RNA polymerase-dependent and -independent systems for cDNA-based rescue of Rift Valley fever virus","volume":"89","author":"Habjan","year":"2008","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib90","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.virol.2008.12.011","article-title":"Efficient production of Rift Valley fever virus-like particles: the antiviral protein MxA can inhibit primary transcription of bunyaviruses","volume":"385","author":"Habjan","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2009.08.002_bib91","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02148-08","article-title":"NSs protein of Rift Valley Fever Virus induces the specific degradation of the double-stranded RNA-dependent protein kinase (PKR)","author":"Habjan","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib92","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1743-422X-2-42","article-title":"Intracellular localization of Crimean-Congo Hemorrhagic Fever (CCHF) virus glycoproteins","volume":"2","author":"Haferkamp","year":"2005","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2009.08.002_bib93","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1749-6632.2001.tb02682.x","article-title":"West Nile virus: Uganda, 1937 to New York City","volume":"951","author":"Hayes","year":"1999","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.antiviral.2009.08.002_bib94","first-page":"1","article-title":"An alphavirus replicon-derived candidate vaccine against Rift Valley fever virus","author":"Heise","year":"2009","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.antiviral.2009.08.002_bib95","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00262-006-0163-5","article-title":"Co-expression of alpha(1,3)galactosyltransferase and Bacillus thuringiensis PIPLC enhances hyperacute rejection of tumor cells","volume":"56","author":"Hellrung","year":"2007","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.antiviral.2009.08.002_bib96","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1002\/cyto.a.20328","article-title":"High-throughput fluorescent screening of transgenic animals: phenotyping and haplotyping","volume":"69","author":"Hellrung","year":"2006","journal-title":"Cytometry A"},{"key":"10.1016\/j.antiviral.2009.08.002_bib97","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/0035-9203(79)90005-1","article-title":"The Rift Valley fever epizootic in Egypt 1977\u201378. 2. Ecological and entomological studies","volume":"73","author":"Hoogstraal","year":"1979","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2009.08.002_bib98","series-title":"Proceedings of 5th International Sheep Veterinary Congress","first-page":"21","article-title":"Investigation of C13 RVF mutant as a vaccine strain","author":"Hunter","year":"2001"},{"key":"10.1016\/j.antiviral.2009.08.002_bib99","first-page":"95","article-title":"Teratogenicity of a mutagenised Rift Valley fever virus (MVP 12) in sheep","volume":"69","author":"Hunter","year":"2002","journal-title":"Onderstepoort. J. Vet. Res."},{"key":"10.1016\/j.antiviral.2009.08.002_bib100","doi-asserted-by":"crossref","first-page":"e1000287","DOI":"10.1371\/journal.ppat.1000287","article-title":"Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation","volume":"5","author":"Ikegami","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2009.08.002_bib101","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.1128\/JVI.79.9.5606-5615.2005","article-title":"Rift valley fever virus nonstructural protein NSs promotes viral RNA replication and transcription in a minigenome system","volume":"79","author":"Ikegami","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib102","doi-asserted-by":"crossref","first-page":"12106","DOI":"10.1128\/JVI.79.18.12106-12111.2005","article-title":"Rift Valley fever virus NSs mRNA is transcribed from an incoming anti-viral-sense S RNA segment","volume":"79","author":"Ikegami","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib103","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1128\/JVI.80.6.2933-2940.2006","article-title":"Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene","volume":"80","author":"Ikegami","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib104","doi-asserted-by":"crossref","first-page":"8421","DOI":"10.1128\/JVI.02641-06","article-title":"Characterization of Rift Valley fever virus transcriptional terminations","volume":"81","author":"Ikegami","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib105","unstructured":"IOE, 2007. Terrestrial Animal Health Code, vol. XI. I.O.o. Epizootics, p. 14.1."},{"key":"10.1016\/j.antiviral.2009.08.002_bib106","article-title":"Lethal viruses\u2014viral hemorrhagic fevers","author":"Jones","year":"2002","journal-title":"Res. Adv. Microbiol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib107","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1128\/AAC.01074-08","article-title":"Activity of T-705 in a hamster model of yellow fever virus infection in comparison with that of a chemically related compound, T-1106","volume":"53","author":"Julander","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2009.08.002_bib108","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/oxfordjournals.aje.a113471","article-title":"A rift Valley fever vaccine trial. I. Side effects and serologic response over a six-month follow-up","volume":"116","author":"Kark","year":"1982","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib109","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0264-410X(85)90060-X","article-title":"A Rift Valley fever vaccine trial: 2. Serological response to booster doses with a comparison of intradermal versus subcutaneous injection","volume":"3","author":"Kark","year":"1985","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2009.08.002_bib110","doi-asserted-by":"crossref","first-page":"30554","DOI":"10.1074\/jbc.M403485200","article-title":"A molecular handoff between bacteriophage T7 DNA primase and T7 DNA polymerase initiates DNA synthesis","volume":"279","author":"Kato","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2009.08.002_bib111","series-title":"Current Topics in Micro. and Immunol., vol. 283","article-title":"Biology of negative stranded RNA viruses: the power of reverse genetics","author":"Kawaoka","year":"2005"},{"key":"10.1016\/j.antiviral.2009.08.002_bib112","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jviromet.2004.12.003","article-title":"A novel rapid fluorescent focus inhibition test for rabies virus using a recombinant rabies virus visualizing a green fluorescent protein","volume":"125","author":"Khawplod","year":"2005","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.antiviral.2009.08.002_bib113","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.meegid.2005.06.002","article-title":"Genetic analysis of dog rabies viruses circulating in Bangkok","volume":"6","author":"Khawplod","year":"2006","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib114","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/clind\/24.4.718","article-title":"Treatment of Bolivian hemorrhagic fever with intravenous ribavirin","volume":"24","author":"Kilgore","year":"1997","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2009.08.002_bib115","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.virol.2003.09.046","article-title":"Sequence determination of the Crimean-Congo hemorrhagic fever virus L segment","volume":"321","author":"Kinsella","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2009.08.002_bib116","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1073\/pnas.052430399","article-title":"Antivirally active MxA protein sequesters La Crosse virus nucleocapsid protein into perinuclear complexes","volume":"99","author":"Kochs","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2009.08.002_bib117","doi-asserted-by":"crossref","first-page":"5679","DOI":"10.1128\/JVI.78.11.5679-5685.2004","article-title":"A bunyamwera virus minireplicon system in mosquito cells","volume":"78","author":"Kohl","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib118","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1101\/SQB.1987.052.01.043","article-title":"The translational requirement for La Crosse virus S-mRNA synthesis","volume":"52","author":"Kolakofsky","year":"1987","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib119","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0166-0934(03)00132-0","article-title":"Enhanced genetic rescue of negative-strand RNA viruses: use of an MVA-T7 RNA polymerase vector and DNA replication inhibitors","volume":"111","author":"Kovacs","year":"2003","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.antiviral.2009.08.002_bib120","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.3201\/eid1408.080082","article-title":"Interepidemic Rift Valley fever virus seropositivity, northeastern Kenya","volume":"14","author":"LaBeaud","year":"2008","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2009.08.002_bib121","doi-asserted-by":"crossref","first-page":"795","DOI":"10.4269\/ajtmh.2007.76.795","article-title":"Spectrum of Rift Valley fever virus transmission in Kenya: insights from three distinct regions","volume":"76","author":"LaBeaud","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2009.08.002_bib122","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1743-422X-6-6","article-title":"Characterisation of immune responses and protective efficacy in mice after immunisation with Rift Valley Fever virus cDNA constructs","volume":"6","author":"Lagerqvist","year":"2009","journal-title":"Virol. J."},{"issue":"Pt 12","key":"10.1016\/j.antiviral.2009.08.002_bib123","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1099\/0022-1317-75-12-3441","article-title":"Localization of Bunyamwera bunyavirus G1 glycoprotein to the Golgi requires association with G2 but not with NSm","volume":"75","author":"Lappin","year":"1994","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib124","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1073\/pnas.92.10.4477","article-title":"Recombinant vesicular stomatitis viruses from DNA","volume":"92","author":"Lawson","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2009.08.002_bib125","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0092-8674(04)00132-1","article-title":"TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus","volume":"116","author":"Le May","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2009.08.002_bib126","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1371\/journal.ppat.0040013","article-title":"A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells","volume":"4","author":"Le May","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2009.08.002_bib127","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1743-422X-5-82","article-title":"Rift Valley fever virus structural proteins: expression, characterization and assembly of recombinant proteins","volume":"5","author":"Liu","year":"2008","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2009.08.002_bib128","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1128\/JVI.69.7.3972-3979.1995","article-title":"The L protein of Rift Valley fever virus can rescue viral ribonucleoproteins and transcribe synthetic genome-like RNA molecules","volume":"69","author":"Lopez","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib129","doi-asserted-by":"crossref","first-page":"5255","DOI":"10.1016\/j.vaccine.2008.07.042","article-title":"Priming with DNA plasmids encoding the nucleocapsid protein and glycoprotein precursors from Rift Valley fever virus accelerates the immune responses induced by an attenuated vaccine in sheep","volume":"26","author":"Lorenzo","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2009.08.002_bib130","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.virol.2004.10.009","article-title":"Efficient bunyavirus rescue from cloned cDNA","volume":"330","author":"Lowen","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2009.08.002_bib131","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s00705-008-0067-0","article-title":"Inhibition of influenza A H3N8 virus infections in mice by morpholino oligomers","volume":"153","author":"Lupfer","year":"2008","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib132","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1517\/14712598.2.8.883","article-title":"Vaccines for category: a bioterrorism diseases","volume":"2","author":"Lutwick","year":"2002","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.antiviral.2009.08.002_bib133","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/0092-8674(89)90766-6","article-title":"Amplification, expression, and packaging of foreign gene by influenza virus","volume":"59","author":"Luytjes","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2009.08.002_bib134","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1086\/378747","article-title":"Rift Valley fever epidemic in Saudi Arabia: epidemiological, clinical, and laboratory characteristics","volume":"37","author":"Madani","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2009.08.002_bib135","doi-asserted-by":"crossref","unstructured":"Mandell, R.B., Koukuntla, R., Staplin, W.R., Kaniewski, L.D., Carzoli, A.K., Freiberg, A., Holbrook, M., Link, C.J., Flick, R., 2009. A safe replication-incompetent Rift Valley fever vaccine: chimeric virus-like particles fully protect rodents in a challenge study. PLoS Pathog., submitted for publication.","DOI":"10.1016\/j.virol.2009.11.001"},{"key":"10.1016\/j.antiviral.2009.08.002_bib136","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1006\/abbi.1996.0547","article-title":"Molecular determinants of Golgi retention in the Punta Toro virus G1 protein","volume":"336","author":"Matsuoka","year":"1996","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.antiviral.2009.08.002_bib137","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJM198601023140104","article-title":"Lassa fever. Effective therapy with ribavirin","volume":"314","author":"McCormick","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2009.08.002_bib138","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0264-410X(86)90007-1","article-title":"Evaluation of a new Rift Valley fever vaccine: safety and immunogenicity trials","volume":"4","author":"Meadors","year":"1986","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2009.08.002_bib139","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/0035-9203(79)90004-X","article-title":"The Rift Valley fever epizootic in Egypt 1977\u201378. 1. Description of the epizzotic and virological studies","volume":"73","author":"Meegan","year":"1979","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2009.08.002_bib140","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/vr.105.6.124","article-title":"An epizootic of Rift Valley fever in Egypt in 1977","volume":"105","author":"Meegan","year":"1979","journal-title":"Vet. Rec."},{"key":"10.1016\/j.antiviral.2009.08.002_bib141","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.antiviral.2007.10.009","article-title":"Treatment of yellow fever","volume":"78","author":"Monath","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2009.08.002_bib142","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0264-410X(91)90314-V","article-title":"Further evaluation of a mutagen-attenuated Rift Valley fever vaccine in sheep","volume":"9","author":"Morrill","year":"1991","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2009.08.002_bib143","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.2460\/ajvr.1987.48.07.1042","article-title":"Pathogenicity and immunogenicity of a mutagen-attenuated Rift Valley fever virus immunogen in pregnant ewes","volume":"48","author":"Morrill","year":"1987","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.antiviral.2009.08.002_bib144","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.2460\/ajvr.1997.58.10.1104","article-title":"Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle","volume":"58","author":"Morrill","year":"1997","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.antiviral.2009.08.002_bib145","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.2460\/ajvr.1997.58.10.1110","article-title":"Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids","volume":"58","author":"Morrill","year":"1997","journal-title":"Am. J. Vet. Res."},{"issue":"Suppl. 4","key":"10.1016\/j.antiviral.2009.08.002_bib146","doi-asserted-by":"crossref","first-page":"S815","DOI":"10.1093\/clinids\/11.Supplement_4.S815","article-title":"Prevention of Rift Valley fever in rhesus monkeys with interferon-alpha","volume":"11","author":"Morrill","year":"1989","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.antiviral.2009.08.002_bib147","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1016\/S0264-410X(03)00131-2","article-title":"Pathogenicity and neurovirulence of a mutagen-attenuated Rift Valley fever vaccine in rhesus monkeys","volume":"21","author":"Morrill","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2009.08.002_bib148","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0923-2516(06)80134-2","article-title":"Rift Valley fever epizootic in the central highlands of Madagascar","volume":"143","author":"Morvan","year":"1992","journal-title":"Res. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib149","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/0923-2516(91)90070-J","article-title":"Rift Valley fever on the east coast of Madagascar","volume":"142","author":"Morvan","year":"1991","journal-title":"Res. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib150","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1089\/vbz.2008.0009","article-title":"Potential vectors of Rift Valley fever virus in the Mediterranean region","volume":"8","author":"Moutailler","year":"2008","journal-title":"Vector Borne Zoonotic Dis."},{"key":"10.1016\/j.antiviral.2009.08.002_bib151","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4269\/ajtmh.1995.53.405","article-title":"Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment","volume":"53","author":"Muller","year":"1995","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2009.08.002_bib152","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1006\/viro.1993.1402","article-title":"Expression of the Bunyamwera virus M genome segment and intracellular localization of NSm","volume":"195","author":"Nakitare","year":"1993","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2009.08.002_bib153","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.virol.2008.12.012","article-title":"Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus","volume":"385","author":"Naslund","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2009.08.002_bib154","first-page":"43","article-title":"Reverse genetics systems for the generation of segmented negative-sense RNA viruses entirely from cloned cDNA","volume":"283","author":"Neumann","year":"2004","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib155","doi-asserted-by":"crossref","first-page":"9345","DOI":"10.1073\/pnas.96.16.9345","article-title":"Generation of influenza A viruses entirely from cloned cDNAs","volume":"96","author":"Neumann","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2009.08.002_bib156","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1099\/0022-1317-83-11-2635","article-title":"A decade after the generation of a negative-sense RNA virus from cloned cDNA\u2014what have we learned?","volume":"83","author":"Neumann","year":"2002","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib157","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0264-410X(85)90061-1","article-title":"Rift Valley fever virus vaccine trial: study of neutralizing antibody response in humans","volume":"3","author":"Niklasson","year":"1985","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2009.08.002_bib158","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0966-842X(03)00208-7","article-title":"Virus-like particles as immunogens","volume":"11","author":"Noad","year":"2003","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib159","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1099\/vir.0.83173-0","article-title":"Rescue of Akabane virus (family Bunyaviridae) entirely from cloned cDNAs by using RNA polymerase I","volume":"88","author":"Ogawa","year":"2007","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib160","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1128\/JVI.02655-06","article-title":"The glycoprotein cytoplasmic tail of Uukuniemi virus (Bunyaviridae) interacts with ribonucleoproteins and is critical for genome packaging","volume":"81","author":"Overby","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib161","doi-asserted-by":"crossref","first-page":"10428","DOI":"10.1128\/JVI.01362-06","article-title":"Generation and analysis of infectious virus-like particles of Uukuniemi virus (bunyaviridae): a useful system for studying bunyaviral packaging and budding","volume":"80","author":"Overby","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib162","doi-asserted-by":"crossref","first-page":"11381","DOI":"10.1128\/JVI.00767-07","article-title":"The cytoplasmic tails of Uukuniemi Virus (Bunyaviridae) G(N) and G(C) glycoproteins are important for intracellular targeting and the budding of virus-like particles","volume":"81","author":"Overby","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib163","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1128\/JVI.66.4.2564-2569.1992","article-title":"Human and mouse Mx proteins inhibit different steps of the influenza virus multiplication cycle","volume":"66","author":"Pavlovic","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib164","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1128\/JVI.01074-06","article-title":"The S segment of Punta Toro virus (Bunyaviridae, Phlebovirus) is a major determinant of lethality in the Syrian hamster and codes for a type I interferon antagonist","volume":"81","author":"Perrone","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib165","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0166-3542(86)90024-0","article-title":"Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator","volume":"6","author":"Peters","year":"1986","journal-title":"Antiviral Res."},{"issue":"Suppl. 2","key":"10.1016\/j.antiviral.2009.08.002_bib166","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.vaccine.2005.01.107","article-title":"Novel human polysaccharide adjuvants with dual Th1 and Th2 potentiating activity","volume":"24","author":"Petrovsky","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2009.08.002_bib167","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.0818-9641.2004.01272.x","article-title":"Vaccine adjuvants: current state and future trends","volume":"82","author":"Petrovsky","year":"2004","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib168","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0264-410X(99)00218-2","article-title":"Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience","volume":"18","author":"Pittman","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2009.08.002_bib169","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1038\/nm1209","article-title":"Vaccines: past, present and future","volume":"11","author":"Plotkin","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2009.08.002_bib170","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.virol.2005.12.026","article-title":"Characterization of Maguari orthobunyavirus mutants suggests the nonstructural protein NSm is not essential for growth in tissue culture","volume":"348","author":"Pollitt","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2009.08.002_bib171","doi-asserted-by":"crossref","first-page":"693","DOI":"10.4269\/ajtmh.1997.57.693","article-title":"Rift Valley fever virus: a seroepidemiologic study of small terrestrial vertebrates in South Africa","volume":"57","author":"Pretorius","year":"1997","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2009.08.002_bib172","doi-asserted-by":"crossref","first-page":"5773","DOI":"10.1002\/j.1460-2075.1995.tb00266.x","article-title":"Rescue of measles viruses from cloned DNA","volume":"14","author":"Radecke","year":"1995","journal-title":"EMBO J."},{"key":"10.1016\/j.antiviral.2009.08.002_bib173","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4049\/jimmunol.93.2.293","article-title":"Immunization against Rift Valley Fever Virus. Studies on the immunogenicity of lyophilized formalin-inactivated vaccine","volume":"93","author":"Randall","year":"1964","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib174","doi-asserted-by":"crossref","first-page":"660","DOI":"10.4049\/jimmunol.89.5.660","article-title":"The development of a formalin-killed Rift Valley fever virus vaccine for use in man","volume":"89","author":"Randall","year":"1962","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib175","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1600-0854.2004.00219.x","article-title":"Missorting of LaCrosse virus nucleocapsid protein by the interferon-induced MxA GTPase involves smooth ER membranes","volume":"5","author":"Reichelt","year":"2004","journal-title":"Traffic"},{"key":"10.1016\/j.antiviral.2009.08.002_bib176","unstructured":"Reynes, J.M., February 2009. Rift Valley Fever in Madagascar 2008 Laboratory Surveillance, RVF OIE Bloemfontein. Institut Pasteur de Madagascar."},{"key":"10.1016\/j.antiviral.2009.08.002_bib177","doi-asserted-by":"crossref","first-page":"10555","DOI":"10.1158\/0008-5472.CAN-05-0627","article-title":"Effective treatment of preexisting melanoma with whole cell vaccines expressing alpha(1,3)-galactosyl epitopes","volume":"65","author":"Rossi","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.antiviral.2009.08.002_bib178","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00262-005-0667-4","article-title":"Complete protection against melanoma in absence of autoimmune depigmentation after rejection of melanoma cells expressing alpha(1,3)galactosyl epitopes","volume":"54","author":"Rossi","year":"2005","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.antiviral.2009.08.002_bib179","series-title":"Virus-Like Particles as a Vaccine Delivery System: Myths and Facts","author":"Roy","year":"2008"},{"key":"10.1016\/j.antiviral.2009.08.002_bib180","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.virol.2006.01.012","article-title":"Rescue of the prototypic Arenavirus LCMV entirely from plasmid","volume":"350","author":"Sanchez","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2009.08.002_bib181","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.3201\/eid0706.010617","article-title":"Vector competence of selected North American Culex and Coquillettidia mosquitoes for West Nile virus","volume":"7","author":"Sardelis","year":"2001","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2009.08.002_bib182","series-title":"Bunyaviridae: The Viruses and Their Replication, vol. 2","author":"Schmaljohn","year":"2001"},{"key":"10.1016\/j.antiviral.2009.08.002_bib183","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0042-6822(89)90365-6","article-title":"Baculovirus expression of the M genome segment of Rift Valley fever virus and examination of antigenic and immunogenic properties of the expressed proteins","volume":"170","author":"Schmaljohn","year":"1989","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2009.08.002_bib184","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1002\/j.1460-2075.1994.tb06739.x","article-title":"Infectious rabies viruses from cloned cDNA","volume":"13","author":"Schnell","year":"1994","journal-title":"EMBO J."},{"key":"10.1016\/j.antiviral.2009.08.002_bib185","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.3201\/eid0812.020195","article-title":"Genetic analysis of viruses associated with emergence of Rift Valley fever in Saudi Arabia and Yemen, 2000\u201301","volume":"8","author":"Shoemaker","year":"2002","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2009.08.002_bib186","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0166-3542(02)00203-6","article-title":"Viruses of the Bunya- and Togaviridae families: potential as bioterrorism agents and means of control","volume":"57","author":"Sidwell","year":"2003","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2009.08.002_bib187","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1440-1711.2004.01290.x","article-title":"Insulin-derived adjuvants efficiently promote both Th1 and Th2 immune responses","volume":"82","author":"Silva","year":"2004","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib188","first-page":"813","article-title":"Elimination of graft versus host disease in matched allogeneic leukemic transplant recipients using CAMPATH-1","volume":"186","author":"Slavin","year":"1985","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib189","first-page":"107","article-title":"Rift Valley fever; isolation of the virus from wild mosquitoes","volume":"29","author":"Smithburn","year":"1948","journal-title":"Br. J. Exp. Pathol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib190","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1016\/j.vaccine.2005.08.034","article-title":"Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus","volume":"24","author":"Spik","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2009.08.002_bib191","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0042-6822(02)00092-2","article-title":"Sin Nombre virus glycoprotein trafficking","volume":"308","author":"Spiropoulou","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2009.08.002_bib192","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0958-1669(96)80076-0","article-title":"Xenogeneic organ transplantation","volume":"7","author":"Squinto","year":"1996","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib193","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.2174\/138161208786071290","article-title":"Inhibition of RNA virus infections with peptide-conjugated morpholino oligomers","volume":"14","author":"Stein","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.antiviral.2009.08.002_bib194","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/jac\/dkn221","article-title":"Treatment of AG129 mice with antisense morpholino oligomers increases survival time following challenge with dengue 2 virus","volume":"62","author":"Stein","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2009.08.002_bib195","series-title":"Infectious Diseases of Livestock","author":"Swanepoel","year":"2004"},{"key":"10.1016\/j.antiviral.2009.08.002_bib196","series-title":"Rift Valley Fever","author":"Swanepoel","year":"2004"},{"key":"10.1016\/j.antiviral.2009.08.002_bib197","series-title":"Infectious Diseases of Livestock With Special Reference to South Africa","article-title":"Rift Valley fever","author":"Swanepoel","year":"2003"},{"key":"10.1016\/j.antiviral.2009.08.002_bib198","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1634\/stemcells.2007-0241","article-title":"Limitations of green fluorescent protein as a cell lineage marker","volume":"25","author":"Swenson","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.antiviral.2009.08.002_bib199","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1089\/vim.2005.18.317","article-title":"Live attenuated measles vaccine as a potential multivalent pediatric vaccination vector","volume":"18","author":"Tangy","year":"2005","journal-title":"Viral Immunol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib200","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1021\/bi00468a024","article-title":"Distribution of Gal alpha 1\u20133Gal beta 1\u20134GlcNAc residues on secreted mammalian glycoproteins (thyroglobulin, fibrinogen, and immunoglobulin G) as measured by a sensitive solid-phase radioimmunoassay","volume":"29","author":"Thall","year":"1990","journal-title":"Biochemistry"},{"key":"10.1016\/j.antiviral.2009.08.002_bib201","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/146532401317070871","article-title":"Highly efficient retroviral gene transfer into immortalized CD34(-) cells and organ distribution after transplantation into NOD\/SCID mice","volume":"3","author":"Thalmeier","year":"2001","journal-title":"Cytotherapy"},{"key":"10.1016\/j.antiviral.2009.08.002_bib202","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000046559","article-title":"Mesenchymal differentiation and organ distribution of established human stromal cell lines in NOD\/SCID mice","volume":"105","author":"Thalmeier","year":"2001","journal-title":"Acta Haematol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib203","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/jmedent\/24.1.11","article-title":"Transmission studies in mosquitoes (Diptera: Culicidae) with disseminated Rift Valley fever virus infections","volume":"24","author":"Turell","year":"1987","journal-title":"J. Med. Entomol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib204","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2987\/08-5791.1","article-title":"Potential for North American mosquitoes to transmit Rift Valley fever virus","volume":"24","author":"Turell","year":"2008","journal-title":"J. Am. Mosq. Control Assoc."},{"key":"10.1016\/j.antiviral.2009.08.002_bib205","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/jmedent\/35.2.132","article-title":"Susceptibility of selected strains of Australian mosquitoes (Diptera: Culicidae) to Rift Valley fever virus","volume":"35","author":"Turell","year":"1998","journal-title":"J. Med. Entomol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib206","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4269\/ajtmh.1990.42.185","article-title":"Transmission of Rift Valley fever virus by the sand fly, Phlebotomus duboscqi (Diptera: Psychodidae)","volume":"42","author":"Turell","year":"1990","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2009.08.002_bib207","first-page":"987","article-title":"Immunity to the alpha(1,3)galactosyl epitope provides protection in mice challenged with colon cancer cells expressing alpha(1,3)galactosyl-transferase: a novel suicide gene for cancer gene therapy","volume":"63","author":"Unfer","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.antiviral.2009.08.002_bib208","unstructured":"USDA, 2005. Agricultural Bioterrorism Protection Act of 2002; possession, use, and transfer of biological agents and toxins. In: USDA, A. (Ed.), Fed Register, vol. Part II. 7 CFR Part 331 and 9 CFR Part 121, pp. 13241\u201313292."},{"key":"10.1016\/j.antiviral.2009.08.002_bib209","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1128\/JVI.74.3.1538-1543.2000","article-title":"The S segment of Rift valley fever phlebovirus (Bunyaviridae) carries determinants for attenuation and virulence in mice","volume":"74","author":"Vialat","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib210","doi-asserted-by":"crossref","first-page":"7181","DOI":"10.1016\/j.vaccine.2006.06.041","article-title":"Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever","volume":"24","author":"Wallace","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2009.08.002_bib211","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.femsle.2005.01.046","article-title":"Reverse genetics of negative-stranded RNA viruses: a global perspective","volume":"244","author":"Walpita","year":"2005","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.antiviral.2009.08.002_bib212","doi-asserted-by":"crossref","first-page":"8388","DOI":"10.1073\/pnas.92.18.8388","article-title":"Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones","volume":"92","author":"Whelan","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2009.08.002_bib213","first-page":"169","article-title":"Outbreaks of Rift Valley fever in Kenya, Somalia and United Republic of Tanzania, December 2006\u2013April","volume":"82","author":"WHO","year":"2007","journal-title":"Wkly. Epidemiol. Rec."},{"key":"10.1016\/j.antiviral.2009.08.002_bib214","doi-asserted-by":"crossref","first-page":"8274","DOI":"10.1128\/JVI.00476-06","article-title":"NSm and 78-kilodalton proteins of Rift Valley fever virus are nonessential for viral replication in cell culture","volume":"80","author":"Won","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib215","doi-asserted-by":"crossref","first-page":"13335","DOI":"10.1128\/JVI.01238-07","article-title":"NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis","volume":"81","author":"Won","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2009.08.002_bib216","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3201\/eid0802.010023","article-title":"An outbreak of Rift Valley fever in Northeastern Kenya, 1997\u201398","volume":"8","author":"Woods","year":"2002","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2009.08.002_bib217","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.virol.2008.08.044","article-title":"Co-selection of West Nile virus nucleotides that confer resistance to an antisense oligomer while maintaining long-distance RNA\/RNA base pairings","volume":"382","author":"Zhang","year":"2008","journal-title":"Virology"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354209004197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354209004197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T18:50:10Z","timestamp":1739299810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354209004197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":217,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0166354209004197"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2009.08.002","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}